600763 通策医疗
已收盘 08-23 15:00:00
资讯
新帖
简况
国金证券给予通策医疗增持评级,业绩平稳增长,种植牙高速放量
每日经济新闻 · 47分钟前
国金证券给予通策医疗增持评级,业绩平稳增长,种植牙高速放量
国金证券:给予通策医疗增持评级
证券之星 · 50分钟前
国金证券:给予通策医疗增持评级
通策医疗(600763):受环境影响业绩承压 种植业务加速恢复
广发证券股份有... · 12:33
通策医疗(600763):受环境影响业绩承压 种植业务加速恢复
开源证券:给予通策医疗买入评级
证券之星 · 09:25
开源证券:给予通策医疗买入评级
通策医疗:8月23日召开董事会会议
每日经济新闻 · 08-24 00:13
通策医疗:8月23日召开董事会会议
医疗服务收入增加,通策医疗上半年营收14.11亿,同比增长3.52% | 财报见闻
华尔街见闻 · 08-23 19:13
医疗服务收入增加,通策医疗上半年营收14.11亿,同比增长3.52% | 财报见闻
通策医疗最新公告:2024年上半年净利润同比增长1.77%
证券之星 · 08-23 17:20
通策医疗最新公告:2024年上半年净利润同比增长1.77%
通策医疗(600763.SH)发布半年度业绩 净利润3.10亿元 同比增长1.77%
智通财经 · 08-23 17:18
通策医疗(600763.SH)发布半年度业绩 净利润3.10亿元 同比增长1.77%
通策医疗:上半年净利润3.098亿元人民币,同比增长1.8%。
美港电讯 · 08-23 17:09
通策医疗:上半年净利润3.098亿元人民币,同比增长1.8%。
通策医疗:2024年半年度净利润增长1.77%
财通社 · 08-23 17:04
通策医疗:2024年半年度净利润增长1.77%
通策医疗08月22日主力资金流出1558万元 连续5日减仓
市场透视 · 08-22
通策医疗08月22日主力资金流出1558万元 连续5日减仓
通策医疗(600763)8月21日主力资金净卖出3934.36万元
证券之星 · 08-22
通策医疗(600763)8月21日主力资金净卖出3934.36万元
医疗服务行业盘中跳水,通策医疗跌0.44%
自选股智能写手 · 08-20
医疗服务行业盘中跳水,通策医疗跌0.44%
通策医疗(600763)8月19日主力资金净卖出2669.88万元
证券之星 · 08-20
通策医疗(600763)8月19日主力资金净卖出2669.88万元
开源证券:给予通策医疗买入评级
证券之星 · 08-20
开源证券:给予通策医疗买入评级
开源证券给予通策医疗买入评级:逆势扩张的口腔连锁龙头企业 业绩有望逐步复苏
每日经济新闻 · 08-20
开源证券给予通策医疗买入评级:逆势扩张的口腔连锁龙头企业 业绩有望逐步复苏
通策医疗08月19日遭主力抛售2302万元 环比增加1001.44%
自选股智能写手 · 08-19
通策医疗08月19日遭主力抛售2302万元 环比增加1001.44%
北向资金8月15日净买入通策医疗7.87万股 连续3日增持
自选股智能写手 · 08-16
北向资金8月15日净买入通策医疗7.87万股 连续3日增持
民营医院概念盘中拉升,通策医疗涨4.16%
自选股智能写手 · 08-15
民营医院概念盘中拉升,通策医疗涨4.16%
辅助生殖概念盘中拉升,通策医疗涨4.36%
自选股智能写手 · 08-15
辅助生殖概念盘中拉升,通策医疗涨4.36%
暂无数据
公司概况
公司名称:
通策医疗股份有限公司
所属行业:
卫生
上市日期:
1996-10-30
主营业务:
通策医疗股份有限公司的主营业务为医疗服务。公司主要产品是口腔医疗服务。公司主要医院为杭州口腔医院集团、宁波口腔医院集团、三叶儿童口腔、其他蒲公英分院。通策医疗连续五年获得德勤中国评选的“中国卓越管理公司”、2022年和2023年连续上榜浙商全国500强、2023年获评新浪财经金麒麟“最受用户信赖的医疗机构”、通策医疗荣获杭州市上城区“行业领军企业”称号、杭州口腔医院集团荣获2023年杭州市人民政府质量奖。
发行价格:
4.08
{"stockData":{"symbol":"600763","market":"SH","secType":"STK","nameCN":"通策医疗","latestPrice":41.71,"timestamp":1724396400000,"preClose":41.1,"halted":0,"volume":4346487,"delay":0,"floatShares":447000000,"shares":447000000,"eps":1.131,"marketStatus":"已收盘","marketStatusCode":5,"change":0.61,"latestTime":"08-23 15:00:00","open":41.08,"high":42.01,"low":40.95,"amount":181000000,"amplitude":0.0258,"askPrice":41.71,"askSize":64,"bidPrice":41.7,"bidSize":175,"shortable":0,"etf":0,"ttmEps":1.131,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"adjPreClose":41.1,"symbolType":"stock","openAndCloseTimeList":[[1724376600000,1724383800000],[1724389200000,1724396400000]],"highLimit":45.21,"lowLimit":36.99,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":447289117,"pbRate":4.69,"roa":"--","roe":"4.45%","epsLYR":1.56,"committee":0.519409,"marketValue":18656000000,"floatMarketCap":18656000000,"peRate":36.878867,"changeRate":0.0148,"turnoverRate":0.0097,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-08-26。"},"requestUrl":"/m/hq/s/600763/tweets","defaultTab":"tweets","newsList":[{"id":"2462628909","title":"国金证券给予通策医疗增持评级,业绩平稳增长,种植牙高速放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2462628909","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462628909?lang=zh_cn&edition=full","pubTime":"2024-08-25 16:42","pubTimestamp":1724575364,"startTime":"0","endTime":"0","summary":"国金证券08月25日发布研报称,给予通策医疗(600763.SH)增持评级。评级理由主要包括:1)种植业务高速放量,口腔门诊人数稳增;2)外延扩张稳步推进,浙江省内开业机构63家;3)经营指标健康,利润率稳定。风险提示:政策性风险;市场竞争加剧风险;人才短缺风险;跨区发展风险;医疗安全性事故纠纷风险等;合规监管风险。AI点评:通策医疗近一个月获得2份券商研报关注,买入2家。文章来源:每日经济新闻原标题:国金证券给予通策医疗增持评级,业绩平稳增长,种植牙高速放量","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408251659149f525862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408251659149f525862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600763"],"gpt_icon":0},{"id":"2462640367","title":"国金证券:给予通策医疗增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2462640367","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462640367?lang=zh_cn&edition=full","pubTime":"2024-08-25 16:40","pubTimestamp":1724575229,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司袁维近期对通策医疗进行研究并发布了研究报告《业绩平稳增长,种植牙高速放量》,本报告对通策医疗给出增持评级,当前股价为41.71元。近年来公司处于扩张期,医疗机构数量以及人员数量持续增加,在持续增加投入以及当前客单价不断变化的影响下仍然保持了毛利率与净利率的稳定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082500002661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"gpt_icon":0},{"id":"2462610568","title":"通策医疗(600763):受环境影响业绩承压 种植业务加速恢复","url":"https://stock-news.laohu8.com/highlight/detail?id=2462610568","media":"广发证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462610568?lang=zh_cn&edition=full","pubTime":"2024-08-25 12:33","pubTimestamp":1724560392,"startTime":"0","endTime":"0","summary":"核心观点:通策医疗发布2024 年半年报。根据公司财报,24 年上半年种植业务实现收入2.55 亿元,同比+11.3%,种植牙集采由23Q2 开始落地,目前正加速恢复中,集采影响已基本出清。根据公司财报,公司上半年毛利率和净利率分别为40.83%和26.03%,分别同比下滑0.53pp 和0.26pp。我们推测毛利率下滑主要受种植牙集采以及正畸业务消费降级影响。随着消费环境逐步恢复,公司业绩有望在未来回归健康增长轨道。医疗事故风险;市场竞争风险;集采政策风险","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408251233159f51bccd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408251233159f51bccd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600763","BK0236","BK0048","BK0096","BK0114","BK0077","BK0146","BK0284"],"gpt_icon":0},{"id":"2462618443","title":"开源证券:给予通策医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2462618443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462618443?lang=zh_cn&edition=full","pubTime":"2024-08-25 09:25","pubTimestamp":1724549117,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,阮帅近期对通策医疗进行研究并发布了研究报告《公司信息更新报告:2024上半年业绩稳健增长,种植业务快速放量》,本报告对通策医疗给出买入评级,当前股价为41.71元。我们看好公司的长期发展,维持公司的盈利预测,预计公司2024-2026年归母净利润为5.59/6.17/6.86亿元,当前股价对应PE为33.4/30.3/27.2倍,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有5家机构给出评级,买入评级5家;过去90天内机构目标均价为75.92。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082500001013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600763"],"gpt_icon":0},{"id":"2461080514","title":"通策医疗:8月23日召开董事会会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2461080514","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461080514?lang=zh_cn&edition=full","pubTime":"2024-08-24 00:13","pubTimestamp":1724429614,"startTime":"0","endTime":"0","summary":"每经AI快讯,通策医疗 8月24日发布公告称,公司第十届第六次董事会会议于2024年8月23日在浙江省杭州市西湖区灵溪北路21号合生国贸中心5号楼会议室以现场结合通讯表决方式召开。审议了《通策医疗股份有限公司关于修订的议案》等。2024年1至6月份,通策医疗的营业收入构成为:医疗服务业占比93.18%,产品销售占比4.45%,建设工程占比1.45%,服务费占比0.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408240013539f4cf06c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408240013539f4cf06c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600763","BK0236","BK0048","BK0096","BK0114","BK0077","BK0284","BK0146"],"gpt_icon":0},{"id":"2461756213","title":"医疗服务收入增加,通策医疗上半年营收14.11亿,同比增长3.52% | 财报见闻","url":"https://stock-news.laohu8.com/highlight/detail?id=2461756213","media":"华尔街见闻","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461756213?lang=zh_cn&edition=full","pubTime":"2024-08-23 19:13","pubTimestamp":1724411617,"startTime":"0","endTime":"0","summary":"8月23日,通策医疗发布2024上半年业绩报告,财报显示:1)主要财务数据:营业收入:半年度公司实现营业收入14.11亿元,较上年同期增长3.52%,主要系医疗服务收入增加所致。值得注意的是,2024年H1,通策医疗口腔医疗门诊量达171万人次,实现总营业收入14.11亿元,比去年同期增长3.52%。修复业务:半年度营业收入2.22亿元,同比增长2.8%,收入占比与上年度持平。截止今日收盘,通策医疗报41.71元/股,上涨1.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408231921189f4c1f39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408231921189f4c1f39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600763"],"gpt_icon":0},{"id":"2461557922","title":"通策医疗最新公告:2024年上半年净利润同比增长1.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461557922","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461557922?lang=zh_cn&edition=full","pubTime":"2024-08-23 17:20","pubTimestamp":1724404859,"startTime":"0","endTime":"0","summary":"通策医疗2024年半年度报告显示,公司上半年实现营业收入14.11亿元,同比增长3.52%;归属于母公司所有者的净利润3.1亿元,同比增长1.77%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082300032255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"gpt_icon":0},{"id":"2461557276","title":"通策医疗(600763.SH)发布半年度业绩 净利润3.10亿元 同比增长1.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461557276","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461557276?lang=zh_cn&edition=full","pubTime":"2024-08-23 17:18","pubTimestamp":1724404698,"startTime":"0","endTime":"0","summary":"智通财经APP讯,通策医疗(600763.SH)披露2024年半年度报告,该公司报告期实现营业收入14.11亿元,同比增长3.52%。归属于上市公司股东的净利润3.10亿元,同比增长1.77%。归属于上市公司股东的扣除非经常性损益的净利润3.06亿元,同比增长4.33%。报告期内,该公司坚持“总院+分院”模式发展,各蒲公英医院建设、运营情况良好,盈亏平衡时间符合公司预期,2024年H1,公司口腔医疗门诊量达171万人次。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1169410.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600763"],"gpt_icon":0},{"id":"2461355216","title":"通策医疗:上半年净利润3.098亿元人民币,同比增长1.8%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2461355216","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461355216?lang=zh_cn&edition=full","pubTime":"2024-08-23 17:09","pubTimestamp":1724404153,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0048","BK0096","BK0236","600763","BK0077","BK0284","BK0114","BK0146"],"gpt_icon":0},{"id":"2461557214","title":"通策医疗:2024年半年度净利润增长1.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461557214","media":"财通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461557214?lang=zh_cn&edition=full","pubTime":"2024-08-23 17:04","pubTimestamp":1724403840,"startTime":"0","endTime":"0","summary":"通策医疗公告,2024年半年度公司实现营业收入14.11亿元,较上年同期增长3.52%;归属于上市公司股东的净利润为3.1亿元,同比增长1.77%。归属于上市公司股东的扣除非经常性损益的净利润为3.06亿元,同比增长4.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408231705269f4ba4a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408231705269f4ba4a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600763"],"gpt_icon":0},{"id":"2461136363","title":"通策医疗08月22日主力资金流出1558万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2461136363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461136363?lang=zh_cn&edition=full","pubTime":"2024-08-22 15:17","pubTimestamp":1724311031,"startTime":"0","endTime":"0","summary":"08月22日, 通策医疗股价跌1.77%,报收41.10元,成交金额1.84亿元,换手率1.00%,振幅2.65%,量比0.73。通策医疗今日主力资金净流出1558万元,连续5日净流出,上一交易日主力净流出3530万元,今日环比减少55.86%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为50.00%,平均跌幅为2.25%。该股近5个交易日下跌7.89%,主力资金累计净流出8166万元;近20日主力资金累计净流出1.77亿元,其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082215192395b30da2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082215192395b30da2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600763","BK0146","BK0284","BK0096","BK0048","BK0114","BK0077","BK0236"],"gpt_icon":0},{"id":"2461247386","title":"通策医疗(600763)8月21日主力资金净卖出3934.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461247386","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461247386?lang=zh_cn&edition=full","pubTime":"2024-08-22 08:21","pubTimestamp":1724286073,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月21日收盘,通策医疗报收于41.84元,下跌2.27%,换手率1.15%,成交量5.12万手,成交额2.16亿元。8月21日的资金流向数据方面,主力资金净流出3934.36万元,占总成交额18.25%,游资资金净流入979.52万元,占总成交额4.54%,散户资金净流入2954.84万元,占总成交额13.7%。融券方面,融券卖出7100.0股,融券偿还3.1万股,融券余量29.27万股,融券余额1224.81万元。通策医疗主营业务:医疗服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082200007470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","BK0236","BK0077","BK0096","BK0146","600763","BK0114","BK0048"],"gpt_icon":0},{"id":"2460015911","title":"医疗服务行业盘中跳水,通策医疗跌0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460015911","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460015911?lang=zh_cn&edition=full","pubTime":"2024-08-20 09:53","pubTimestamp":1724118794,"startTime":"0","endTime":"0","summary":"08月20日,医疗服务行业盘中跳水,截至09点53分,医疗服务行业整体指数下跌1.03%,报4003.010点。从个股上来看,该行业的成分股中,通策医疗跌0.44%,迪安诊断、南模生物、华大基因跌幅居前。从资金上来看,截止发稿,医疗服务行业主力净流入为-8274.84万,其中兰卫医学受到资金热捧,主力净流入597.05万;拉长时间线来看,该板块近20日主力资金净流入-34.59亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082009531494200fc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082009531494200fc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","BK0077","BK0146","BK0114","BK0236","BK0096","BK0048","600763"],"gpt_icon":0},{"id":"2460094709","title":"通策医疗(600763)8月19日主力资金净卖出2669.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460094709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460094709?lang=zh_cn&edition=full","pubTime":"2024-08-20 08:25","pubTimestamp":1724113518,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月19日收盘,通策医疗报收于43.3元,下跌2.26%,换手率1.52%,成交量6.82万手,成交额2.98亿元。8月19日的资金流向数据方面,主力资金净流出2669.88万元,占总成交额8.97%,游资资金净流入373.71万元,占总成交额1.26%,散户资金净流入2296.17万元,占总成交额7.71%。融券方面,融券卖出2100.0股,融券偿还6.33万股,融券余量37.62万股,融券余额1629.12万元。通策医疗主营业务:医疗服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082000006081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763","BK0236","BK0048","BK0096","BK0114","BK0077","BK0284","BK0146"],"gpt_icon":0},{"id":"2460099578","title":"开源证券:给予通策医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2460099578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460099578?lang=zh_cn&edition=full","pubTime":"2024-08-20 07:40","pubTimestamp":1724110825,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,阮帅近期对通策医疗进行研究并发布了研究报告《公司首次覆盖报告:逆势扩张的口腔连锁龙头企业,业绩有望逐步复苏》,本报告对通策医疗给出买入评级,当前股价为43.3元。2023年,公司口腔医疗门诊量达到335.33万人次,同比增长13.8%,实现总收入28.47亿元,同比增长4.70%,实现归母净利润5亿元,同比下降8.72%。最新盈利预测明细如下:该股最近90天内共有4家机构给出评级,买入评级4家;过去90天内机构目标均价为75.92。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082000005336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763","161027"],"gpt_icon":0},{"id":"2460509188","title":"开源证券给予通策医疗买入评级:逆势扩张的口腔连锁龙头企业 业绩有望逐步复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2460509188","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460509188?lang=zh_cn&edition=full","pubTime":"2024-08-20 07:40","pubTimestamp":1724110823,"startTime":"0","endTime":"0","summary":"开源证券08月20日发布研报称,给予通策医疗(600763.SH,最新价:43.3元)买入评级。评级理由主要包括:1)立足浙江、全国布局的口腔连锁龙头企业;2)口腔医疗行业发展前景良好,细分市场发展空间较大;3)坚持“区域总院+分院”发展模式,推进省内市场下沉。风险提示:医疗风险、竞争风险、声誉风险等。AI点评:通策医疗近一个月获得1份券商研报关注。文章来源:每日经济新闻原标题:开源证券给予通策医疗买入评级:逆势扩张的口腔连锁龙头企业,业绩有望逐步复苏","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408200749379f3b7933&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408200749379f3b7933&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["161027","600763"],"gpt_icon":0},{"id":"2460870956","title":"通策医疗08月19日遭主力抛售2302万元 环比增加1001.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460870956","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460870956?lang=zh_cn&edition=full","pubTime":"2024-08-19 15:18","pubTimestamp":1724051916,"startTime":"0","endTime":"0","summary":"08月19日, 通策医疗股价跌2.26%,报收43.30元,成交金额2.98亿元,换手率1.52%,振幅5.40%,量比1.10。通策医疗今日主力资金净流出2302万元,上一交易日主力净流出209万元,今日环比增加1001.44%。该股近5个交易日下跌0.30%,主力资金累计净流出2958万元;近20日主力资金累计净流出1.62亿元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081915302495a5f847&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081915302495a5f847&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600763","BK0236","BK0048","BK0096","BK0114","BK0077","BK0146","BK0284"],"gpt_icon":0},{"id":"2459231414","title":"北向资金8月15日净买入通策医疗7.87万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2459231414","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459231414?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:30","pubTimestamp":1723771817,"startTime":"0","endTime":"0","summary":"8月15日, 北向资金增持通策医疗7.87万股,连续3日增持。截止当日收盘,沪股通共持有通策医疗786.69万股,占流通股1.75%。沪股通增持金额前五个股分别为中国平安、招商银行、中信证券、贵州茅台、拓普集团。通策医疗近5个交易日下跌0.34%,沪股通累计增持13.74万股;近20个交易日下跌1.15%,沪股通累计增持1.94万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093136959ceeb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093136959ceeb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0146","BK0048","BK0236","BK0114","BK0077","BK0096","600763","BK0284"],"gpt_icon":0},{"id":"2459693914","title":"民营医院概念盘中拉升,通策医疗涨4.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459693914","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459693914?lang=zh_cn&edition=full","pubTime":"2024-08-15 10:33","pubTimestamp":1723689181,"startTime":"0","endTime":"0","summary":"08月15日,民营医院概念盘中拉升,截至10点32分,民营医院概念整体指数上涨1.04%,报1379.330点。从个股上来看,该概念的成分股中,通策医疗涨4.16%,莎普爱思、*ST景峰、朗玛信息涨幅居前。从资金上来看,截止发稿,民营医院概念主力净流入为1.02亿,其中京东方A受到资金热捧,主力净流入7915.11万;拉长时间线来看,该板块近20日主力资金净流入-47.33亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151033019682671a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151033019682671a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","600763","BK0236","BK0114","BK0096","BK0284","BK0146","BK0048"],"gpt_icon":0},{"id":"2459461550","title":"辅助生殖概念盘中拉升,通策医疗涨4.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459461550","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459461550?lang=zh_cn&edition=full","pubTime":"2024-08-15 10:31","pubTimestamp":1723689098,"startTime":"0","endTime":"0","summary":"08月15日,辅助生殖概念盘中拉升,截至10点31分,辅助生殖概念整体指数上涨1.02%,报385.430点。从个股上来看,该概念的成分股中,通策医疗涨4.36%,凯普生物、浙江医药、利德曼涨幅居前。从资金上来看,截止发稿,辅助生殖概念主力净流入为-2.10亿,其中浙江医药受到资金热捧,主力净流入2115.37万;拉长时间线来看,该板块近20日主力资金净流入-20.07亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815103138968266fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815103138968266fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0236","BK0028","600216","BK0048","600763","BK0239","BK0146","BK0077","BK0114","BK0191","BK0284","BK0096"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1996-10-30","address":"浙江省杭州市上城区平海路57号","stockEarnings":[{"period":"1week","weight":-0.0585},{"period":"1month","weight":-0.0266},{"period":"3month","weight":-0.0292},{"period":"6month","weight":-0.0932},{"period":"1year","weight":-0.4447},{"period":"ytd","weight":-0.2296}],"companyName":"通策医疗股份有限公司","boardCode":"AI0083","perCapita":"5551股","boardName":"卫生","registeredCapital":"44728万元","compareEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0164},{"period":"3month","weight":-0.0759},{"period":"6month","weight":-0.0501},{"period":"1year","weight":-0.0739},{"period":"ytd","weight":-0.0405}],"survey":" 通策医疗股份有限公司的主营业务为医疗服务。公司主要产品是口腔医疗服务。公司主要医院为杭州口腔医院集团、宁波口腔医院集团、三叶儿童口腔、其他蒲公英分院。通策医疗连续五年获得德勤中国评选的“中国卓越管理公司”、2022年和2023年连续上榜浙商全国500强、2023年获评新浪财经金麒麟“最受用户信赖的医疗机构”、通策医疗荣获杭州市上城区“行业领军企业”称号、杭州口腔医院集团荣获2023年杭州市人民政府质量奖。","serverTime":1724578181237,"listedPrice":4.08,"stockholders":"80569人(较上一季度减少1.83%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通策医疗(600763)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通策医疗(600763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通策医疗,600763,通策医疗股票,通策医疗股票老虎,通策医疗股票老虎国际,通策医疗行情,通策医疗股票行情,通策医疗股价,通策医疗股市,通策医疗股票价格,通策医疗股票交易,通策医疗股票购买,通策医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通策医疗(600763)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通策医疗(600763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}